Genetic Sequencing tests in Dubai & UAE

Compare available Genetic Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

256

Listed price range

2,600.00–5,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic Sequencing test prices

Showing 91–105 of 256 matching tests.

Genetic Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3681 FAN1 Gene Interstitial Nephritis Karyomegalic Genetic Test This test evaluates the FAN1 gene for pathogenic variants associated with Karyomegalic Interstitial Nephritis (KIN).	Whole Blood (EDTA) or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FAN1 gene"] Parameters [] Preparation ["No fasting required"] Indications ["Confirmation of clinical suspicion of KIN", "Familial screening for KIN", "Reproductive risk counseling"] Measurement technique Confirm with laboratory Codes LOINC: 58536-9 ICD-10: N11.8, Z15.8, N18.9 Clinical summary This test evaluates the FAN1 gene for pathogenic variants associated with Karyomegalic Interstitial Nephritis (KIN).
TEST-5379 FAS Gene Autoimmune Lymphoproliferative Syndrome Type 1A (ALPS) Genetic Test This genetic test analyzes the FAS gene for mutations associated with Autoimmune Lymphoproliferative Syndrome Type 1A (ALPS).	Whole Blood (2-5 mL EDTA), Extracted DNA, or FTA Card Dried Blood Spot	3-4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FAS gene mutations", "Single nucleotide variants", "Small indels"] Parameters [] Preparation ["Provide detailed clinical history", "Attend pre-test genetic counselling session"] Indications ["Clinical suspicion of ALPS", "Familial cascade testing", "Lymphoma risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 94087-9 ICD-10: D89.82 Clinical summary This genetic test analyzes the FAS gene for mutations associated with Autoimmune Lymphoproliferative Syndrome Type 1A (ALPS).
TEST-4404 FAT1 Gene Sequencing (Facioscapulohumeral Dystrophy‑like Phenotype) Test This test evaluates the FAT1 gene for pathogenic variants associated with facioscapulohumeral muscular dystrophy-like phenotypes.	Peripheral Whole Blood or FTA Card (DNA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FAT1 gene sequence", "Copy Number Variations (CNV) in FAT1 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any anticoagulation therapy"] Indications ["Suspicion of facioscapulohumeral muscular dystrophy-like phenotype", "Family history of FSHD-like conditions", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G71.0 Clinical summary This test evaluates the FAT1 gene for pathogenic variants associated with facioscapulohumeral muscular dystrophy-like phenotypes.
TEST-2201 FAT4 Gene Van Maldergem Syndrome Type 2 Genetic Test This genetic test evaluates the FAT4 gene for mutations associated with Van Maldergem syndrome type 2.	Whole Blood (EDTA) or Saliva (Buccal Swab)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FAT4 gene sequence variants"] Parameters [] Preparation [] Indications ["Suspected Van Maldergem syndrome type 2", "Confirmation of clinical diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 82101-1 ICD-10: Q87.89 Clinical summary This genetic test evaluates the FAT4 gene for mutations associated with Van Maldergem syndrome type 2.
TEST-2620 FBN1 Gene (Marfan/Lipodystrophy) Genetic Test This test evaluates the FBN1 gene for pathogenic variants associated with Marfan syndrome and lipodystrophy.	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FBN1 gene"] Parameters [] Preparation ["No fasting required.", "Detailed clinical history required.", "Prior genetic counseling session mandatory.", "Provide relevant medical reports and completed pedigree chart at collection."] Indications ["Diagnosis of Marfan syndrome", "Familial risk assessment", "Personalized clinical management", "Differentiation from other connective tissue disorders", "Metabolic management guidance for lipodystrophy"] Measurement technique Confirm with laboratory Codes LOINC: 21647-4 ICD-10: Q87.4, E88.1 Clinical summary This test evaluates the FBN1 gene for pathogenic variants associated with Marfan syndrome and lipodystrophy.
TEST-2381 FGFR2 Gene Saethre-Chotzen Syndrome Genetic Test This test identifies pathogenic variants within the FGFR2 gene associated with Saethre-Chotzen syndrome.	Peripheral whole blood	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FGFR2 gene pathogenic variants", "Craniosynostosis genetic cause"] Parameters [] Preparation ["No special preparation needed", "Clinical history form required"] Indications ["Suspected Saethre-Chotzen syndrome", "Family history of craniosynostosis", "Need for genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q87.0 Clinical summary This test identifies pathogenic variants within the FGFR2 gene associated with Saethre-Chotzen syndrome.
TEST-2360 FGFR2 Gene Sequencing for Craniosynostosis & Dysmorphology (NGS) Test This diagnostic test evaluates the entire coding region of the FGFR2 gene for pathogenic variants associated with craniosynostosis syndromes and related conditions.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 weeks (21–28 working days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FGFR2 gene sequence", "Pathogenic variants in FGFR2"] Parameters [] Preparation [] Indications ["Syndromic craniosynostosis", "Familial history of craniosynostosis", "Dysmorphic features suggestive of FGFR2-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21636-0 ICD-10: Q87.0 Clinical summary This diagnostic test evaluates the entire coding region of the FGFR2 gene for pathogenic variants associated with craniosynostosis syndromes and related conditions.
TEST-4415 FLNA Gene FG Syndrome Type 2 Genetic Test This test evaluates the FLNA gene for pathogenic variants associated with FG syndrome type 2.	Peripheral Whole Blood	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FLNA gene", "Copy number variants in the FLNA gene"] Parameters [] Preparation ["No fasting required", "Prior genetic counselling session mandatory"] Indications ["Clinical suspicion of FG syndrome type 2", "Brain malformations", "Developmental delay", "Family history of FG syndrome type 2"] Measurement technique Confirm with laboratory Codes LOINC: 94854-3 ICD-10: Q87.8 Clinical summary This test evaluates the FLNA gene for pathogenic variants associated with FG syndrome type 2.
TEST-5596 FLNA Gene Otopaladigital Syndrome Type 1 Genetic Test This diagnostic test evaluates the FLNA gene for pathogenic variants associated with Otopaladigital syndrome type 1.	Peripheral whole blood (3–5 mL in EDTA tube), extracted DNA, or FTA card blood spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FLNA gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["No fasting required"] Indications ["Suspected Otopaladigital syndrome type 1", "Family history of Otopaladigital syndrome type 1", "Genetic counseling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 59410-4 ICD-10: Q87.8 Clinical summary This diagnostic test evaluates the FLNA gene for pathogenic variants associated with Otopaladigital syndrome type 1.
TEST-4512 FLNA Gene Terminal Osseous Dysplasia Genetic Test This test evaluates the FLNA gene for pathogenic variants associated with terminal osseous dysplasia with pigmentary defects.	Peripheral whole blood (3–5 mL in EDTA tube) or FTA card blood spot	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FLNA gene sequence", "Pathogenic variants in FLNA"] Parameters [] Preparation ["No special preparation needed", "Clinical history and genetic counselling session mandatory before testing"] Indications ["Clinical suspicion of FLNA-related dysplasia", "Family members of affected probands", "Research cohorts investigating skeletal and pigmentary pathways"] Measurement technique Confirm with laboratory Codes LOINC: 94207-1 ICD-10: Q87.0 Clinical summary This test evaluates the FLNA gene for pathogenic variants associated with terminal osseous dysplasia with pigmentary defects.
TEST-5304 FOLR1 Gene Analysis for Cerebral Folate Transport Deficiency Genetic Test \| 2800 AED \| 2026 DHA Guidelines This genetic test identifies mutations in the FOLR1 gene associated with cerebral folate transport deficiency.	Peripheral Whole Blood or FTA Card Spot	21–28 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FOLR1 gene sequence", "Copy number variations in FOLR1"] Parameters [] Preparation ["No special dietary preparation required", "Inform the laboratory about current medications and supplements"] Indications ["Suspected cerebral folate transport deficiency", "Individuals with unexplained neurological regression, developmental delay, or movement disorders"] Measurement technique Confirm with laboratory Codes LOINC: 94015-0 ICD-10: E53.8 (G31.89) Clinical summary This genetic test identifies mutations in the FOLR1 gene associated with cerebral folate transport deficiency.
TEST-5181 GATA2 Gene Emberger Syndrome Genetic Test This genetic test identifies pathogenic germline mutations in the GATA2 gene associated with Emberger Syndrome.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot	3–4 Weeks (21–28 business days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation [] Indications ["Unexplained lymphedema before age 30", "Personal or family history of MDS or AML at a young age", "Persistent monocytopenia with B-cell and NK-cell lymphopenia", "Known family history of GATA2-related disease"] Measurement technique Confirm with laboratory Codes LOINC: 85401-6 ICD-10: D46.9, I89.0 Clinical summary This genetic test identifies pathogenic germline mutations in the GATA2 gene associated with Emberger Syndrome.
TEST-4400 GATA6 Gene Atrial Septal Defect Type 9 Genetic Test This genetic test identifies pathogenic variants in the GATA6 gene associated with atrial septal defect type 9.	Peripheral Whole Blood (EDTA) or DNA FTA Card	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GATA6 gene"] Parameters [] Preparation [] Indications ["Personal or family history of atrial septal defect", "Early-onset or multiple congenital heart anomalies"] Measurement technique Confirm with laboratory Codes LOINC: 10304-5 ICD-10: Q21.1 Clinical summary This genetic test identifies pathogenic variants in the GATA6 gene associated with atrial septal defect type 9.
TEST-4162 GATA6 Gene Pancreatic Agenesis and Congenital Heart Defects Genetic Test This test identifies pathogenic mutations within the GATA6 gene associated with pancreatic agenesis and congenital heart defects.	Peripheral whole blood (preferred), buccal swab, or dried blood spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GATA6 gene mutations", "Pathogenic variants in GATA6 coding regions and splice sites"] Parameters [] Preparation ["No specific fasting required.", "Inform the lab of any medications being taken."] Indications ["Infants, children, or adults presenting with congenital heart defects and unexplained pancreatic insufficiency.", "Family members following identification of a confirmed GATA6 mutation."] Measurement technique Confirm with laboratory Codes LOINC: 77673-8 ICD-10: Q45.0, Q24.8, Z13.79 Clinical summary This test identifies pathogenic mutations within the GATA6 gene associated with pancreatic agenesis and congenital heart defects.
TEST-3710 GCM2 Gene Familial Isolated Hypoparathyroidism Genetic Test This genetic test detects pathogenic variants in the GCM2 gene associated with familial isolated hypoparathyroidism.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GCM2 gene"] Parameters [] Preparation ["Genetic counselling session recommended", "Pedigree chart of affected family members recommended"] Indications ["Suspected familial isolated hypoparathyroidism", "Family history of hypoparathyroidism", "Recurrent hypocalcemia"] Measurement technique Confirm with laboratory Codes LOINC: 79219-2 ICD-10: E20.8 Clinical summary This genetic test detects pathogenic variants in the GCM2 gene associated with familial isolated hypoparathyroidism.

Category overview

Genetic Sequencing: overview

Achieving a definitive diagnosis for multi-system or exceptionally rare disorders requires reading the deepest layers of your foundational biological code. As the pinnacle of our advanced Genetics department, Genetic Sequencing (including Whole Exome or Whole Genome testing) provides an incredibly detailed, high-resolution scan of your DNA. By leveraging state-of-the-art Next-Generation Sequencing technology, this expansive molecular screening helps uncover elusive genetic variants that standard tests miss, safely guiding your healthcare provider in tailoring highly personalized medical treatments and opening doors to advanced precision medicine. Consistently trusted for advanced genomic analysis across premier diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, exceptional analytical precision, and highly efficient reporting. Secure the definitive insights your health requires—book your genetic sequencing testing in UAE, arrange a secure clinical sample collection, or consult our dedicated medical genetics experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.